These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5402493)

  • 21. [Threatened abortion. Development and treatment].
    Maretti M; Vitiello N; Lacreta O
    Matern Infanc (Sao Paulo); 1970; 29(1):71-8. PubMed ID: 5516901
    [No Abstract]   [Full Text] [Related]  

  • 22. [Progesterone and abortion].
    Hashiguchi S
    Sanfujinka No Jissai; 1969 Dec; 18(13):1140-6. PubMed ID: 5395804
    [No Abstract]   [Full Text] [Related]  

  • 23. Threatened abortion, hormone therapy and malformed embryos.
    Oakley GP
    Teratology; 1979 Dec; 20(3):481-2. PubMed ID: 542900
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of threatened abortion with progestational hormones].
    Montanari GD; Marconato A; Moscolo GF; Montagner P
    Minerva Ginecol; 1969 May; 21(10):683-4. PubMed ID: 5402494
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of therapy in threatened abortion].
    Baranovskaia FS; Kovtunova LG; Pelipenko VI
    Pediatr Akus Ginekol; 1971; 1():41-4. PubMed ID: 5092100
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preventive treatment of spontaneous abortion, such as it results from the study of mechanism of contraction and relaxation of uterine muscle].
    Kato K; Ishida M; Higashi Y; Nakanishi S
    Gynecol Prat; 1972; 23(2):89-94. PubMed ID: 4636769
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of a new progestogen in the therapy of threatened abortion].
    Surace M; Crosignani PG; Campana G
    Minerva Ginecol; 1967 Jun; 19(11):608-12. PubMed ID: 5611221
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of oxyprogesterone-capronate in threatened abortion].
    Pashchenko AG
    Vopr Okhr Materin Det; 1968 Apr; 13(4):59-63. PubMed ID: 5703209
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hormonal profile in threatened abortion and its treatment with HCG].
    Desanso G; Lalario R; Cenderelli G; D'Addato F; Surico N; Visentin L
    Minerva Ginecol; 1981 May; 33(5):421-8. PubMed ID: 7254663
    [No Abstract]   [Full Text] [Related]  

  • 30. [The pathogenesis of diabetes insipidus in pregnancy (description of a case)].
    Laghi A; Tomasillo MR
    Arch Ostet Ginecol; 1980; 85(4):297-305. PubMed ID: 7344669
    [No Abstract]   [Full Text] [Related]  

  • 31. A clinical trial and cytological assessment of enol LUTEOVIS IN THE TREATMENT OF THREATENED AND RECURRENT ABORTION.
    Burton ER; Wachtel EG
    J Obstet Gynaecol Br Commonw; 1967 Aug; 74(4):533-6. PubMed ID: 5340429
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of threatened abortion].
    Saito K
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Aug; 19(8):885-6. PubMed ID: 5625774
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vitamin K in obstetrics--effects of vitamin K1 on threatened abortion and premature labor].
    Hata Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Nov; 19(11):1398-401. PubMed ID: 5627227
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of 6-dehydro-retro-progesterone; especially in comparison with the effect of 17-alpha-ethynyl-19-nortestosterone].
    Yamamoto K
    Zasshi Tokyo Ika Daigaku; 1968 Jul; 26(3):385-403. PubMed ID: 5750349
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of turinal and progesterone combined with chorionic gonadotropin on cellular immunity during the treatment of threatened abortion in the first and second trimesters].
    Zhuchenko PG; Lisovskaia TV; Gordiĭchuk VD
    Akush Ginekol (Mosk); 1988 Dec; (12):24-7. PubMed ID: 3266544
    [No Abstract]   [Full Text] [Related]  

  • 36. [Are progestational agents indicated in threatened abortion?].
    Ned Tijdschr Geneeskd; 1975 Nov; 119(48):1904-5. PubMed ID: 1214899
    [No Abstract]   [Full Text] [Related]  

  • 37. Physiology should be supported with evidence in progesterone administration for threatened miscarriage.
    Sotiriadis A; Makrydimas G
    Am J Reprod Immunol; 2005 Oct; 54(4):240. PubMed ID: 16135015
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug-induced eosinophilia in progesterone therapy].
    Abragam KA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):91. PubMed ID: 5752886
    [No Abstract]   [Full Text] [Related]  

  • 39. [Control of the effect of treatment in late threatened abortions using the DU-1 Dynamo-uterograph].
    Tsenov D; Penev I; Tsankov Ts
    Akush Ginekol (Sofiia); 1982; 21(1):11-5. PubMed ID: 7081613
    [No Abstract]   [Full Text] [Related]  

  • 40. [Value of chlormadinone (synthetic progesterone) in threat of abortion].
    Notter A; Durand PM
    Lyon Med; 1969 Mar; 221(12):659-69. PubMed ID: 4187874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.